Janette Garin
Former Secretary of Health of the Philippines
- Facts1
- Drivers1
- Indicators2
- Related people0
Former Secretary of Health of the Philippines
Factrail analysis (disputed / needs review): oversaw the rollout of the Dengvaxia program that was later suspended following a manufacturer safety warning, an episode associated with a documented drop in public vaccine confidence. The model asserts no individual culpability — it links only the documented program decisions and their measured effects, and treats the record as source-sensitive.
Janette Garin’s slice of Factrail’s verified causal web — the facts, drivers and welfare indicators their actions connect to. Select any node to trace a path.
Loading network…
Projected scenarios from the Factrail model. These describe what may happen under stated assumptions — they are not confirmed facts and may change as new data arrives.
Horizon: Jun 9, 2026 – Dec 31, 2027
Under a baseline in which global immunization investment only partially recovers and vaccine hesitancy stays elevated, MCV1 coverage holds near its 83-84% plateau and the global under-five mortality rate continues to fall but more slowly, remaining above the SDG 3.2 normal line of 25 per 1,000 through 2027.
Assumptions
Assumes no major new donor surge or pandemic-scale disruption; immunization-investment intensity stays near its partially recovered ~0.75 level; vaccine hesitancy remains elevated relative to pre-2017; ~14.5 million zero-dose children are only gradually reduced. A baseline, not a worst case.
This is a projected scenario, not a confirmed fact.
Updated
A chronology will appear once enough dated facts are linked.
No affiliated people are linked yet.
Janette Garin enters Factrail's public-health record through a single, tightly bounded episode rather than a career. As Philippine Secretary of Health she supervised the rollout of the Department of Health's school-based Dengvaxia program — a mass dengue-vaccination drive that was later suspended after the manufacturer warned the vaccine could raise the risk of severe dengue in people not previously infected. The model attaches this contribution to her through the Department of Health rather than to her individually, codes it as "complex" and small in magnitude, and flags the whole entry as disputed and in need of review. The discipline of that scope is the substance of the analysis: what follows traces how one program decision travels through Factrail's causal model, and, just as importantly, how much the model deliberately declines to assert.
The anchor of the record is the 2017 suspension of the Dengvaxia program, logged as an action with high source confidence in the underlying event but carrying a "needs review" verification status on its downstream interpretation. The distinction is worth holding onto. That the program was rolled out and later suspended after a manufacturer safety warning is treated as documented public record. What the model treats far more cautiously is the chain of consequence that runs from that suspension toward later public-health outcomes.
Factrail frames Garin's role here as supervisory and institutional. The contribution is recorded against the health ministry she led, with a responsibility factor of one-half and a deliberately small contribution-size weighting — the model's way of saying that a program decision sits inside a collective administrative apparatus, not on one official's shoulders alone. This is an analytical choice rather than a finding about intent, and it is the reason the aggregate welfare score attached to her profile lands near zero.
From the program decision the model routes a single behavioural driver: vaccine hesitancy and erosion of public trust in immunization. The dataset notes that the Dengvaxia episode is widely cited as one contributing factor in declining vaccine confidence in the Philippines, and that this decline is associated in adjacent records with a measured drop in routine immunization coverage. The driver-to-outcome step is where the model's hedging becomes most visible, because the link between the 2017 suspension and later hesitancy is genuinely contested in the public-health literature, and Garin is not a named actor in any downstream outbreak fact.
That single driver then connects to two welfare indicators that pull in opposite directions, which is exactly why the record is coded "complex." The first is first-dose measles vaccination coverage, a "higher is better" measure where the net modeled impact is negative (-0.36): if eroded confidence depresses routine immunization, measles coverage falls, and that is a welfare loss. The second is the under-five mortality rate, a "lower is better" measure where the net impact is positive (+0.24), meaning upward pressure on child deaths — again a welfare loss, expressed through a different sign convention.
Both downstream signals point the same way in welfare terms — toward harm through weakened immunization — even though the raw numbers carry opposite arithmetic signs because the two indicators are scored in opposite directions.
The individual rating impacts make the structure concrete. The largest single entry is a small contribution onto under-five mortality, valued at roughly +0.04 with a positive direction, indicating a marginal increase in modeled child-mortality pressure. A second entry runs onto measles coverage at about -0.06, a modeled reduction in coverage. Both are tiny in absolute terms, and both carry a confidence modifier below one — a numerical acknowledgment that the evidence is soft. These are not findings that Garin caused outbreaks or deaths; they are the model's heavily discounted expression of the direction a contested program decision pushes toward.
The most important feature of this entry is its restraint. Factrail asserts no individual culpability. It links only the documented program decisions and their modeled effects, and the rationale states plainly that the record remains contested. The "disputed / needs review" flag is not decorative: it signals that the causal pathway between the 2017 suspension and later immunization decline is debated, that the connection is treated as documented-but-uncertain, and that the values should be read as provisional pending further verification.
Several limitations are built into the record by design. The contribution is attached to an institution, not solely to a person, so the model resists collapsing a ministry-wide program into one individual's account. The indicators are global aggregates — worldwide measles coverage and under-five mortality — rather than Philippine-specific series, so the chain expresses the kind of pressure the decision pushes toward, scaled down sharply, not a literal forecast for any one country. And the confidence modifiers and small magnitudes mean the entry barely moves the aggregate score at all. The near-zero result is not a verdict of neutrality so much as a measure of how lightly and cautiously the model chooses to weigh a contested record.
Read correctly, Garin's Factrail entry is a study in how a causal platform handles a politically charged and scientifically disputed episode without overreaching. A real, dated, verifiable event — the suspension of a mass-vaccination program after a safety warning — is recorded; its plausible but contested downstream effects on vaccine confidence, immunization coverage, and child survival are traced through an explicit chain; and every step is discounted, hedged, and flagged. The value of the entry lies precisely in what it refuses to do. It does not convert association into blame, it does not treat a contested pathway as settled fact, and it does not let a near-zero score masquerade as a clean bill of health. It shows what can responsibly be attributed to a documented decision, marks where the evidence becomes contested, and leaves the rest open for review.